The founder of the Blueprint longevity project addresses his recent autoimmune gastritis diagnosis while maintaining his commitment to biological optimization.
The Swedish Society of Medicine honors an intensive care specialist for her work in developing ethical frameworks for clinical prioritization in crisis settings.
Professor Dariush Farhud and composer Hamed Mokhtarani are synthesizing historical research with multimedia art to broaden public engagement with Iranian heritage.
Investors are weighing Eli Lilly’s aggressive reinvestment in obesity pipelines against AbbVie’s cash-generative approach to clinical expansion.
Dr Moleboheng Mokhele is translating her research into practical educational tools designed to foster scientific literacy among young children.
The University of Chicago Medicine has appointed Josh Denny to a newly created leadership role to spearhead artificial intelligence and precision medicine initiatives.
New biomarker data indicates that aglatimagene besadenovec maintains immune system activity in prostate cancer patients two years after treatment.
New clinical data suggests that psychiatric conditions are becoming more chronic, challenging existing treatment models and public health strategies.
Medical advancements in pediatric rheumatology are frequently negated by administrative hurdles and outdated insurance coverage policies.
Medical professionals in Hampton Roads are working to shift the perception of hospice from a final resort to a strategic model for managing terminal illness.
New research highlights how ingrained prescribing habits and slow guideline adoption contribute to the continued overuse of common medications among older adults.
The institution integrates a new veterinary medicine track into its academic health network to advance a unified approach to human and animal health.
The London-based biotechnology firm will use its latest funding to scale biological foundation models and advance a pipeline of AI-designed therapeutic candidates.
The organization concludes its 2026 summer program, focusing on training local talent in precision medicine and conservation genomics.
Medical experts warn that elective, full-body imaging for healthy individuals often leads to overdiagnosis and unnecessary medical intervention.
The biotechnology firm reports record financial gains while expanding its clinical footprint in solid-tumor oncology through new trial data and increased manufacturing capacity.
Medical consensus is shifting toward a spectrum-based approach to alcohol use disorder, challenging traditional models of lifelong abstinence.
The hedge fund is moving beyond public market investments by launching a new biotechnology firm focused on long-acting antibody treatments for atopic dermatitis.
The hedge fund is moving beyond public market investments by launching a new biotechnology firm focused on long-acting antibody treatments for atopic dermatitis.
